(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
Diabetic Neuropathy
A study to assess the safety and efficacy of an investigational medication in people with neuropathic pain associated with diabetic neuropathy. Volunteers at least 18 who have diabetes mellitus (type I or II) that is controlled by oral or parenteral hypoglycemic agents or diet and who have a diagnosis of painful diabetic distal symmetric sensory/motor polyneuropathy may be eligible. Research sites located throughout the United States.
More Information
Please see http://www.centerwatch.com/patient/studies/cat253.html.
-----
Lung Cancer
A study to assess the safety and efficacy of an investigational medication in people with advanced non-small cell lung cancer. Volunteers with a histologic and/or cytologic diagnosis of locally-advanced or metastatic non-small cell lung cancer who are not curable by conventional therapy may be eligible. Research sites located throughout the United States.
More Information
Please see http://www.centerwatch.com/patient/studies/cat34.html.
-----
Ovarian Cancer
A study of an investigational medication for patients with ovarian cancer. Female volunteers at least 18 years old who have a diagnosis of epithelial cancer of the ovary, fallopian tube or primary peritoneal cancer and whose cancer has progressed after platinum-based chemotherapy may be eligible. Research sites located throughout the United States.
More Information
Please see http://www.centerwatch.com/patient/studies/cat186.html.
-----
Copyright 2003 CenterWatch. All rights reserved.
